Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1968 to 2017 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
985\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3720.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4264.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
544.28\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
986\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6436.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6980.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
543.94\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
987\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
maguk p55 subfamily member 3 (mpp3 protein) (discs, large homolog 3). [source:swissprot;acc:q13368]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6660.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7301.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09636\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin-tyrosine ligase. [source:refseq;acc:nm\_153712]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5511.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6054.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
543.51\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
988\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial precursor (ec 1.5.5.1) (etf-qo) (etf-ubiquinone oxidoreductase) (etf dehydrogenase) (electron-transferring- flavoprotein dehydrogenase). [source:swissprot;acc:q16134]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6618.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7161.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
542.93\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 n (ec 6.3.2.19) (ubiquitin-protein ligase n) (ubiquitin carrier protein n) (ubc13) (bendless-like ubiquitin conjugating enzyme). [source:swissprot;acc:q16781]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6229.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6829.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0963\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
989\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
541.37\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducing adaptor molecule 2; stam-like protein containing sh3 and itam domains 2. [source:refseq;acc:nm\_005843]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11743.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10712.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09624\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
990\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein 4 (vasa homolog). [source:swissprot;acc:q9nqi0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5147.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5641.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09584\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
541.37\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
991\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transformer-2 protein homolog (tra-2 alpha). [source:swissprot;acc:q13595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6472.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7092.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09583\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
992\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromosome 3p21.1 gene sequence. [source:refseq;acc:nm\_013286]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5393.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5909.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09569\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
993\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6499.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7121.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09568\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 19 (rgs19) (g-alpha interacting protein) (gaip protein). [source:swissprot;acc:p49795]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
994\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin-4 induced protein 1 precursor (fig-1 protein). [source:swissprot;acc:q96rq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5800.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6355.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09563\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative rna-binding protein 15 (rna binding motif protein 15) (one-twenty two protein). [source:swissprot;acc:q96t37]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
995\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5778.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6328.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09516\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 20 (rgs20) (regulator of gz- selective protein signaling 1) (gz-selective gtpase-activating protein) (g(z)gap). [source:swissprot;acc:o76081]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
996\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5110.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5596.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09512\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor lbx1. [source:swissprot;acc:p52954]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
997\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mosaic protein lgn. [source:swissprot;acc:p81274]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5144.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0951\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
998\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 17 (rgs17). [source:swissprot;acc:q9ugc6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5144.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0951\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
999\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(o), alpha subunit 1. [source:swissprot;acc:p09471]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
triacylglycerol lipase, gastric precursor (ec 3.1.1.3) (gastric lipase) (gl). [source:swissprot;acc:p07098]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.095\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1000\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba304i5.1 (novel lipase) (fragment). [source:sptrembl;acc:q96lg2]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rap1 gtpase-activating protein 1 (rap1gap). [source:swissprot;acc:p47736]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.49\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1001\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal acid lipase/cholesteryl ester hydrolase precursor (ec 3.1.1.13) (lal) (acid cholesteryl ester hydrolase) (sterol esterase) (lipase a) (cholesteryl esterase). [source:swissprot;acc:p38571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.095\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, proline-and glutamine-rich (polypyrimidine tract- binding protein-associated splicing factor) (ptb-associated splicing factor) (psf) (dna-binding p52/p100 complex, 100 kda subunit). [source:swissprot;acc:p23246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10178.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9638.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
540.42\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1002\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.095\vspace{3pt}}\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
triacylglycerol lipase, gastric precursor (ec 3.1.1.3) (gastric lipase) (gl). [source:swissprot;acc:p07098]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
539.69\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1003\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba304i5.1 (novel lipase) (fragment). [source:sptrembl;acc:q96lg2]\vspace{3pt}}&&&&\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase (ec 6.1.1.11) (serine--trna ligase) (serrs). [source:swissprot;acc:p49591]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1.095\vspace{3pt}}\\\cline{1-3}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1004\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal acid lipase/cholesteryl ester hydrolase precursor (ec 3.1.1.13) (lal) (acid cholesteryl ester hydrolase) (sterol esterase) (lipase a) (cholesteryl esterase). [source:swissprot;acc:p38571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
539.69\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
o-sialoglycoprotein endopeptidase. [source:refseq;acc:nm\_017807]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5391.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5903.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09498\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1005\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5780.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6329.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09497\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
539.69\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1006\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09485\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase (ec 6.1.1.11) (serine--trna ligase) (serrs). [source:swissprot;acc:p49591]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
539.69\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1007\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5706.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6245.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
539.05\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09485\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1008\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin accessibility complex protein 1 (chrac-1) (chrac-15) (huchrac15) (dna polymerase epsilon subunit p15). [source:swissprot;acc:q9nrg0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2554.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3093.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
538.89\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09485\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1009\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparin sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.-) (n- hsst) (n-heparin sulfate sulfotransferase) (glucosaminyl n- deacetylase/n-sulfotransferase). [source:swissprot;acc:p52849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5210.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5749.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
538.75\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/